Stay updated on Daratumumab Response Adapted Therapy in Elderly Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Response Adapted Therapy in Elderly Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Response Adapted Therapy in Elderly Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.6%
    Check dated 2026-10-24T18:38:21.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T20:39:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, reflecting a site version update.
    Difference
    0.1%
    Check dated 2026-10-10T20:48:48.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The study history now shows Revision: v3.7.0, updating the record from the previous v3.6.6 and signaling a new version of the entry.
    Difference
    0.1%
    Check dated 2026-09-19T18:48:17.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    A new Revision: v3.6.6 entry has been added to the study record history, signaling an update to the latest revision. The References section and the older Revision: v3.6.5 entry have been removed, reshaping how past materials are accessed.
    Difference
    0.2%
    Check dated 2026-08-29T18:05:52.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The study record now shows a Completed status as of 2026-08-20 with Recruitment Status updated accordingly, replacing the previous Active, not recruiting label.
    Difference
    0.5%
    Check dated 2026-08-22T13:37:02.000Z thumbnail image

Stay in the know with updates to Daratumumab Response Adapted Therapy in Elderly Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Response Adapted Therapy in Elderly Myeloma Clinical Trial page.